Metronidazole-induced encephalopathy: A case report and review of the literature

Journal of Clinical Pharmacology

Volumn 51, Issue 1, 2011, Pages 112-116

  Bottenberg, Michelle M ^a   Hegge, Karly A ^b   Klug Eastman, Darla ^a   Kumar, Ravinder ^c  

^a DRAKE UNIVERSITY   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

^c IOWA METHODIST MEDICAL CENTER   (United States)

Author keywords

cerebellum; encephalopathy; magnetic resonance imaging; Metronidazole

Indexed keywords

FLUOXETINE; INSULIN GLARGINE; LISINOPRIL; METRONIDAZOLE; OMEPRAZOLE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; ATAXIA; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSARTHRIA; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION;

ANTI-INFECTIVE AGENTS; BRAIN DISEASES; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METRONIDAZOLE; MIDDLE AGED;

EID: 78650811192     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010362905     Document Type: Article

References (23)

1. Freeman CD, Klutman NE, Lamp KC Metronidazole: a therapeutic review and update. Drugs. 1997 ; 54: 679-708.
2. Petrin D., Degalty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998 ; 11: 300-317.
3. Al Sibae MR, McGuire BM Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009 ; 5: 617-626.
4. Carter MJ, Lobo AJ, Travis SP ; IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2005 ; 54: 566.
5. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994 ; 18: 422-427.
6. Kornbluth A., Sachar DB ; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004 ; 99: 1371-1385.
7. Morgan MH, Read AE, Speller DC Treatment of hepatic encephalopathy with metronidazole. Gut. 1982 ; 23: 1-7.
8. Ralph ED Clinical pharmacokinetics of metronidazole. Clin Pharmacokinet. 1983 ; 8: 43-62.
9. Snavely SR, Hodges GR The neurotoxicity of antibacterial agents. Ann Int Med. 1984 ; 101: 92-104.
10. Boyce EG, Cookson ET, Bond WS Persistent metronidazole-induced peripheral neuropathy. DICP. 1990 ; 24: 19-21.
11. Ahmed A., Loes DJ, Bressler EL Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology. 1995 ; 45: 588-589.
12. Horlen CK, Seifert CF, Malouf CS Toxic metronidazole-induced MRI changes. Ann Pharmacother. 2000 ; 34: 1273-1275.
13. Arik N., Cengiz N., Bilge A. Metronidazole-induced encephalopathy in a uremic patient: a case report. Nephron. 2001 ; 89: 108-109.
14. Cecil KM, Halsted MJ, Schapiro M., Dinopoulos A., Jones BV Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr. 2002 ; 26: 948-951.
15. Woodruff BK, Wijdicks EF, Marshall WF Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med. 2002 ; 346: 68-69.
16. Seok JI, Hanseung Y., Song YM, Lee WY Metronidazole-induced encephalopathy and inferior olivary hypertrophy. Arch Neurol. 2003 ; 60: 1796-1800.
17. Ito H., Maruyama M., Ogura N., et al. Reversible cerebellar lesions induced by metronidazole therapy for Helicobacter pylori. J Neuroimaging. 2004 ; 14: 369-371.
18. Kim DW, Park JM, Yoon BW, Baek MJ, Kim JE, Kim SY Metronidazole-induced encephalopathy. J Neurol Sci. 2004 ; 15 ; 224: 107-111.
19. Hammami N., Drissi C., Sebai R., et al. Reversible metronidazole-induced encephalopathy. J Neuroradiol. 2007 ; 34: 133-136.
20. Kim E., Na DG, Kim EY, Kim JH, Son KR, Chang KH MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. Am J Neuroradiol. 2007 ; 28: 1652-1658.
21. Patel K., Green-Hopkins I., Lu S., Tunkel AR Cerebellar ataxia following prolonged use of metronidazole: case report and literature review [published online ahead of print June 3, 2008]. Int J Infect Dis. 2008 ; 12: e111 - e114.
22. Bradley WG, Karlsson IJ, Rassol CG Metronidazole neuropathy. Br Med J. 1997 ; 3: 610-611.
23. Naranjo CA, Busto U., Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30: 239-245.